James S. Koopman

7.0k total citations · 1 hit paper
92 papers, 5.0k citations indexed

About

James S. Koopman is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, James S. Koopman has authored 92 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 33 papers in Epidemiology and 22 papers in Modeling and Simulation. Recurrent topics in James S. Koopman's work include COVID-19 epidemiological studies (22 papers), HIV/AIDS Research and Interventions (21 papers) and Adolescent Sexual and Reproductive Health (16 papers). James S. Koopman is often cited by papers focused on COVID-19 epidemiological studies (22 papers), HIV/AIDS Research and Interventions (21 papers) and Adolescent Sexual and Reproductive Health (16 papers). James S. Koopman collaborates with scholars based in United States, United Kingdom and Canada. James S. Koopman's co-authors include Ira M. Longini, Arnold S. Monto, Carl G. Simon, John A. Jacquez, Kathryn H. Jacobsen, Betsy Foxman, Lisa Sattenspiel, John P. Fox, Joseph N. S. Eisenberg and Stephen E. Chick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Science of The Total Environment.

In The Last Decade

James S. Koopman

91 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causal inference and counterfactual prediction in machine learning for actionable healthcare

2020 219 citations James S. Koopman et al. profile →

Peers

Countries citing papers authored by James S. Koopman

Since Specialization

Citations

This map shows the geographic impact of James S. Koopman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Koopman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Koopman more than expected).

Fields of papers citing papers by James S. Koopman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Koopman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Koopman. The network helps show where James S. Koopman may publish in the future.

Co-authorship network of co-authors of James S. Koopman

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Koopman. A scholar is included among the top collaborators of James S. Koopman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Koopman. James S. Koopman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Population Partitioning on the Probability of Silent Circulation of Poliovirus 2022 ·Bulletin of Mathematical Biology ·(unknown), Carl A. B. Pearson, James S. Koopman, Thomas J. Hladish	1
2	Evaluating the probability of silent circulation of polio in small populations using the silent circulation statistic 2019 ·Infectious Disease Modelling ·(unknown), Carl A. B. Pearson, James S. Koopman, Thomas J. Hladish	4
3	Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped 2017 ·Epidemics ·James S. Koopman, Christopher J. Henry, (unknown), Marisa C. Eisenberg, Edward L. Ionides, Joseph N. S. Eisenberg	17
4	The dynamics of methicillin-resistant Staphylococcus aureusexposure in a hospital model and the potential for environmental intervention 2013 ·BMC Infectious Diseases ·Nottasorn Plipat, Ian H. Spicknall, James S. Koopman, Joseph N. S. Eisenberg	37
5	Episodic HIV Risk Behavior Can Greatly Amplify HIV Prevalence and the Fraction of Transmissions from Acute HIV Infection 2012 ·PubMed ·Xinyu Zhang, Lin Zhong, Ethan Romero-Severson, Shah Jamal Alam, Christopher J. Henry, Erik Volz, James S. Koopman	21
6	Heterogeneity in Number and Type of Sexual Contacts in a Gay Urban Cohort 2012 ·PubMed ·Ethan Romero-Severson, Shah Jamal Alam, Erik Volz, James S. Koopman	18
7	HIV transmissions by stage in dynamic sexual partnerships 2012 ·Journal of Theoretical Biology ·Jong‐Hoon Kim, James S. Koopman	8
8	Detectable signals of episodic risk effects on acute HIV transmission: Strategies for analyzing transmission systems using genetic data 2012 ·Epidemics ·Shah Jamal Alam, (unknown), Ethan Romero-Severson, Christopher J. Henry, Lin Zhong, Erik Volz, Bluma Brenner, James S. Koopman	13
9	Causal System Modeling in Chronic Disease Epidemiology: A Proposal 2007 ·Annals of Epidemiology ·Roberta B. Ness, James S. Koopman, Mark S. Roberts	38
10	Infection Transmission Science and Models 2005 ·Japanese Journal of Infectious Diseases ·James S. Koopman	20
11	Maximizing statistical power in group-randomized vaccine trials 2005 ·Epidemiology and Infection ·Thomas W. Riggs, James S. Koopman	2
12	Declining hepatitis A seroprevalence: a global review and analysis 2004 ·Epidemiology and Infection ·Kathryn H. Jacobsen, James S. Koopman	251
13	New Data and Tools for Integrating Discrete and Continuous Population Modeling Strategies 2001 ·Annals of the New York Academy of Sciences ·James S. Koopman, Geoffrey M. Jacquez, Stephen E. Chick	28
14	Bias reduction for risk ratio and vaccine effect estimators 2001 ·Statistics in Medicine ·Stephen E. Chick, Daniel Barth-Jones, James S. Koopman	8
15	Infection transmission system models for microbial risk assessment 2001 ·The Science of The Total Environment ·Stephen E. Chick, James S. Koopman, Sada Soorapanth, Mary E. Brown	25
16	Monte Carlo simulation experiments for analysis of HIV vaccine effects and vaccine trial design 2000 ·Winter Simulation Conference ·Daniel Barth-Jones, Andrew L. Adams, James S. Koopman	5
17	Analysis and simulation of a stochastic, discrete-individual model of STD transmission with partnership concurrency 2000 ·Mathematical Biosciences ·Stephen E. Chick, Andrew L. Adams, James S. Koopman	37
18	The ecological effects of individual exposures and nonlinear disease dynamics in populations. 1994 ·American Journal of Public Health ·James S. Koopman, Ira M. Longini	148
19	The Link Between Sexually Transmitted Disease Clinics and HIV Counseling and Testing Centers: Who Is Not Getting Referred? 1992 ·AIDS Education and Prevention ·(unknown), James S. Koopman, David Ostrow, Jill G. Joseph, D. A. Fletcher, (unknown), JoAnne E. Natale	1
20	Behavioral change in longitudinal studies: adoption of condom use by homosexual/bisexual men. 1990 ·American Journal of Public Health ·Jill G. Joseph, S M Adib, James S. Koopman, David G. Ostrow	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact